AIG1 and hepatocellular carcinoma: Previous studies have determined AIG1 may serve as a new biomarker for the diagnosis and prognostic evaluation of HCC and is associated with the thiopurine treatment of acute lymphoblastic leukemia (Choi et al., 2019).